Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly

Nephrology Dialysis Transplantation

Volumn 29, Issue 9, 2014, Pages 1757-1763

  Chudek, Jerzy ^a   Kocełak, Piotr ^a   Owczarek, Aleksander ^a   Bozentowicz Wikarek, Maria ^a   Mossakowska, Małgorzata ^b   Olszanecka Glinianowicz, Magdalena ^a   Wiecek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

Chronic kidney disease; Elderly population; Fibroblast growth factor 23

Indexed keywords

ALBUMIN; CALCIFEDIOL; CALCIUM; CREATININE; CYSTATIN C; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS; UREA; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR;

AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; UPREGULATION; BLOOD; CHRONIC KIDNEY FAILURE; DISEASE COURSE; KIDNEY; MIDDLE AGED; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84907398864     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu063     Document Type: Article

References (27)

1. Riminucci M, Collins MT, Fedarko NS et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003; 112: 683-692
2. Baum M, Schiavi S, Dwarakanath V et al. Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules. Kidney Int 2005; 68: 1148-1153
3. Gattineni J, Bates C, Twombley K et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Renal Physiol 2009; 297: F282-F291
4. Miyamoto K, Ito M, Kuwahara M et al. Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial 2005; 9: 331-335
5. Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 2008; 118: 3820-3828
6. Ito N, Fukumoto S, Takeuchi Y et al. Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 2007; 25: 419-422
7. Kocełak P, Olszanecka-Glinianowicz M, Chudek J. Fibroblast growth factor 23-structure, function and role in kidney diseases. Adv Clin Exp Med 2012; 21: 391-401
8. Gutierrez O, Isakova T, Rhee E et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2205-2215
9. Shimada T, Hasegawa Y, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2001; 98: 6500-6505
10. Ix JH, Shlipak MG, Wassel CL et al. Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol Dial Transplant 2010; 25: 993-997
11. Filler G, Liu D, Huang AH et al. Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease. Clin Biochem 2011; 44: 435-437
12. Bledowski P, Mossakowska M, Chudek J et al. Medical, psychological, social, and economic aspects of aging in Poland (PolSenior): research assumptions and objectives. Exp Gerontol 2011; 46: 1003-1009
13. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1990; 130: 461-470
14. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 1: A0828
15. Cockcroft DW, Gault HM. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
16. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024-2031
17. Levy AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-27
18. World Health Organization. Technical report series 894. Obesity: preventing and managing the global epidemic. World Health Organization: Geneva, 2000
19. Kaiser MJ, Bauer JM, Ramsch C et al. Validation of the Mini Nutritional Assessment Short-Form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging 2009; 13: 782-788
20. Leski JM, Owczarek AJ. A time-domain-constrained fuzzy clustering method and its application to signal analysis. Fuzzy Sets Syst 2005; 155: 165-190
21. Becker BJ, Wu MJ. The synthesis of regression slopes in meta-analysis. Stat Sci 2007; 22: 414-429
22. Levin A, Bakris GL, Moltich M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease. Kidney Int 2007; 71: 31-38
23. Shigematsu T, Kazama J, Yamashita T et al. Possible involvement of circulating fibrobast factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 2004; 44: 250-256
24. Evenepoel P, Meijers B, Viaene I et al. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol 2010; 5: 1268-1276
25. Isakowa T, Wahl P, Vargas G et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79: 1370-1378
26. Pavik I, Jaeger P, Ebner L et al. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant 2013; 28: 352-359
27. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 79-83